DaBomb Protein Biotech Corp. (TPEX:6578)

DaBomb Protein Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	139.81	132.17	253.59	379.99	195.18	197.14
Trading Asset Securities	-	-	-	0.08	-	-
Cash & Short-Term Investments	139.81	132.17	253.59	380.07	195.18	197.14
Cash Growth	-37.28%	-47.88%	-33.28%	94.73%	-0.99%	-25.78%
Accounts Receivable	52.19	39.97	32.28	51.25	36.99	56.04
Other Receivables	1.46	2.12	2.76	1.08	1.44	1.07
Receivables	53.65	42.09	35.05	52.34	38.42	57.11
Inventory	29.8	19.05	34.07	20.23	52.79	37.68
Prepaid Expenses	3.77	3.9	3.87	4.89	19.54	39.97
Other Current Assets	28.91	28.47	327.59	321.31	36.84	69.73
Total Current Assets	255.94	225.68	654.16	778.83	342.76	401.62
Property, Plant & Equipment	829.82	832.71	621.59	564.83	888.09	876.14
Long-Term Investments	-	-	-	-	0.18	0.04
Other Intangible Assets	0.17	0.19	0.21	0.19	0.28	0.37
Long-Term Deferred Tax Assets	5.41	7.29	8.55	12.31	13.85	9.2
Other Long-Term Assets	29.39	29.9	30.76	45.74	34.92	49.12
Total Assets	1,121	1,096	1,315	1,402	1,280	1,336

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16.05	12.59	13.9	9.14	28.5	10.47
Accrued Expenses	11.34	7.33	12.88	11.05	11.8	17.22
Short-Term Debt	38	28	90	92	95	161
Current Portion of Long-Term Debt	20.42	26.18	30.98	238.29	66.66	18.47
Current Portion of Leases	0.35	0.52	1.14	0.98	1.37	1.51
Current Unearned Revenue	0.27	0.03	-	0.23	2.4	-
Other Current Liabilities	11.54	9.84	30.09	5.08	12.64	13.86
Total Current Liabilities	97.97	84.49	178.98	356.77	218.37	222.53
Long-Term Debt	9.73	19.43	45.41	85.7	330.94	433.22
Long-Term Leases	-	0.09	0.6	0.63	1.61	3.81
Long-Term Unearned Revenue	-	-	0.22	0.65	1.42	2.41
Long-Term Deferred Tax Liabilities	3.68	2.48	0.75	0.08	0.55	0.28
Total Liabilities	111.38	106.48	225.96	443.83	552.88	662.24

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	719.42	719.42	679.86	597.1	395.14	330.82
Additional Paid-In Capital	271.78	338.7	355.25	344.46	286.31	246.9
Retained Earnings	26.45	-55.26	26.31	4.3	61.32	105.98
Comprehensive Income & Other	-8.29	-13.59	27.89	12.21	-15.56	-9.46
Shareholders' Equity	1,009	989.28	1,089	958.06	727.2	674.24
Total Liabilities & Equity	1,121	1,096	1,315	1,402	1,280	1,336

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	68.49	74.21	168.13	417.6	495.59	618.01
Net Cash (Debt)	71.32	57.96	85.45	-37.53	-300.41	-420.87
Net Cash Growth	-16.86%	-32.18%	-	-	-	-
Net Cash Per Share	0.99	0.81	1.19	-0.70	-7.76	-12.96
Filing Date Shares Outstanding	71.94	71.94	67.99	59.71	39.51	33.08
Total Common Shares Outstanding	71.94	71.94	67.99	59.71	39.51	33.08
Working Capital	157.97	141.19	475.19	422.07	124.39	179.09
Book Value Per Share	14.03	13.75	16.02	16.05	18.40	20.38
Tangible Book Value	1,009	989.09	1,089	957.88	726.92	673.88
Tangible Book Value Per Share	14.03	13.75	16.02	16.04	18.40	20.37
Land	401.07	401.07	401.07	401.07	401.07	400.92
Buildings	320.3	313.83	138.81	133.06	320.83	317.42
Machinery	309.76	304.77	187.52	177.46	291.48	256.69
Construction In Progress	1.71	1.56	51.76	-	0.24	1.42
Leasehold Improvements	46.56	51.75	25.83	25.31	54.72	53.41

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error